Nexortest Technologies | Your Gateway to Global Market Entry

Brazil Medical Devices Key Update: Upload Your IFU to ANVISA’s Repository Within 30 Days 

ANVISA IFU upload

If you are a manufacturer who sells medical devices in Brazil market, approval comes with a deadline attached. ANVISA’s 2026 approval resolutions repeat the same rule each time: upload your instructions for use (IFU) to the ANVISA document repository within 30 days. Here is what the official 2026 texts say and how to stay compliant. The Brazil Ministry of Health published a Resolution-RE No. 3,087. 

What Resolution RE 3087 Says

Resolution-RE 3087 (Resolução-RE nº 3.087) is dated 6 August 2026 and was published in the Federal Official Gazette (DOU) on 10 August 2026. Article 1 approves a list of device petitions. Article 2 then sets out two duties: 

  • The ANVISA IFU upload to the medical device document repository on ANVISA’s portal is mandatory. The company holding the notification or registration must do it and, by doing so, attests that the content complies with current law and matches the approved product. 
  • The upload must be completed within 30 days of DOU publication, for new notified or registered products and for changes to products already approved. 

This is not a one-off. Resolution RE 1.760 of 29 April 2026, published on 4 May 2026, contains the same clause. The Brazil IFU 30-day rule is a standing condition that comes with every approval.  

Article 3: This Resolution enters into force on the date of its publication. 

The Legal Basis: ANVISA RDC 751 

Both resolutions point to Article 33, paragraphs 4 and 5 of ANVISA RDC 751 for medical devices and of RDC 830 for in vitro diagnostics. These regulations create the repository duty, and each 2026 approval resolution applies it to a new batch of products. 

What ANVISA’s 2026 Manual Adds

On 25 August 2026, ANVISA released two guidance manuals, one for IVD regularization and one for notification of Class I and II health materials. ANVISA describes them as non-binding guidance meant to standardize dossiers and reduce technical requests and rejections. The ANVISA notification manual has a section on the repository.  

Key points: 

  • Including every regularized device in the repository is mandatory. 
  • For health materials, the upload is filed under petition subject 80202, “MATERIAL – Disponibilização de Instruções de Uso no Portal da Anvisa”. 
  • The notification holder is responsible for the upload and must keep control of uploads for possible audits. 
  • The IFU must be complete and consistent with the documents filed in the notification petition. 

The manual also spells out the stakes. ANVISA can review uploaded IFU at any time, ask for corrections, withdraw IFU or restore an earlier version. Non-compliant or inconsistent content can lead to penalties under Law 6,437/1977, and ANVISA may suspend sale, import or use until adequate IFU is uploaded. 

Where eIFU Fits 

The repository is ANVISA’s public copy of your IFU. Giving users IFU in a non-printed, electronic format is a separate question. The 2026 manual notes that digital availability of IFU must meet specific criteria set out in Chapter VI, Section II of RDC 751. Brazil eIFU requirements should be checked for each device before you move away from paper. 

A Simple 30-Day Checklist 

  • Track DOU publications for your products every week 
  • Have final, approved IFU ready before approval arrives 
  • File the correct upload petition as soon as your product is published 
  • Check that the uploaded IFU matches your notification or registration dossier 
  • Keep uploading records for audits 

Conclusion 

ANVISA’s 2026 texts send a consistent message: approval and IFU upload now go together. Build the 30-day window into your launch plan instead of treating it as paperwork after approval. A missed or inconsistent upload is not a small slip, because it can lead to penalties and even a halt on sales. 

How NexorTest Can Help 

NexorTest offers ANVISA medical device registration support for Brazil. Our team can help you plan your submission and post-approval steps, including your ANVISA IFU upload. Contact us to speak with our regulatory experts. 

Meet Our Regulatory Expert

Picture of Dr. Pabbisetty PBS Kumar

Dr. Pabbisetty PBS Kumar

Chief Compliance Officer at NexorTest Technologies

Newsletter

Sign up our newsletter to get update information, promotion or insight.

Latest Article

Scroll to Top